BioForce Nanosciences (OTCMKTS:BFNH – Get Free Report) posted its quarterly earnings data on Monday. The company reported $0.01 earnings per share (EPS) for the quarter, Zacks reports.
BioForce Nanosciences Stock Performance
Shares of OTCMKTS:BFNH traded down $0.03 on Monday, hitting $2.23. The company’s stock had a trading volume of 9,450 shares, compared to its average volume of 5,974. The company has a 50-day simple moving average of $1.56 and a 200 day simple moving average of $0.93. BioForce Nanosciences has a 1 year low of $0.18 and a 1 year high of $2.30.
BioForce Nanosciences Company Profile
BioForce Nanosciences, Inc develops and markets precision instrumentation and proprietary technologies for the production and application of nanoscale materials. Its core platform employs nozzle-driven electrohydrodynamic processes to generate and deposit nanofibers, nanowires and nanoparticles with tight control over diameter, morphology and spatial arrangement. By tailoring electric field parameters and solution properties, the technology enables reproducible fabrication of structures at the nanometer scale.
The company’s product portfolio includes desktop electrospinning systems for nanofiber fabrication, electrospray modules for nanoparticle synthesis and integrated tools for bioprinting and surface patterning.
Featured Stories
- Five stocks we like better than BioForce Nanosciences
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Receive News & Ratings for BioForce Nanosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioForce Nanosciences and related companies with MarketBeat.com's FREE daily email newsletter.
